Journal article
AMPK activation in the treatment of liver disease
Abstract
Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic lipid accumulation, is most common liver disorder with an estimated prevalence of 20-30%. The spectrum of liver pathology in NAFLD ranges from steatosis to more serious disorders, such as non-alcoholic steatohepatitis, fibrosis and chirrosis with increased risk of liver failure and development of hepatocellular carcinoma. Furthermore, NAFLD is an important risk factor for …
Authors
Galic S; Loh K; Kemp BE; Steinberg GR
Journal
Proceedings for Annual Meeting of The Japanese Pharmacological Society, Vol. WCP2018, No. 0, pp. sy83–sy83
Publisher
Japanese Pharmacological Society
Publication Date
2018
DOI
10.1254/jpssuppl.wcp2018.0_sy83-3
ISSN
2435-4953